Kyolic Brain Energy
Kyolic Brain Energy by Wakunaga is a nootropic supplement formulated to support cognitive function, earning an N+ Score of 79 and a 'B-' grade. This product features 5 ingredients with 100% label transparency. It provides clinically studied dosages of Folic Acid (600 mcg) and Vitamin K1 (120 mcg). Key active ingredients include 400 mg of Aged Garlic Extract, 300 mg of Bacopa monnieri extract, and 250 mg of Cognizin Citicoline. Research suggests that ingredients like Bacopa monnieri may support memory and cognitive processing, while citicoline is commonly used for brain health. This supplement may be beneficial for individuals looking to support overall brain health and mental acuity.
About This Product
Kyolic Brain Energy by Wakunaga is a nootropics supplement containing 5 active ingredients. It has earned an N+ Score of 79/100 (Grade B-).
This product features a fully transparent label with individual ingredient amounts disclosed, and key ingredients are present at clinically effective doses based on peer-reviewed research.
Notable clinical-dose ingredients include Folic Acid, Vitamin K1.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Key ingredients at clinically effective doses
- +Fully transparent label with individual ingredient amounts disclosed
- +Broad ingredient diversity exceeding category norms
- +2 ingredient(s) at clinical dose levels
Weaknesses
- −Missing several expected ingredients for its category
Ingredient Analysis (5 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Folic Acid | 600.000 mcg | Optimal |
| Vitamin K1 | 120.000 mcg | Optimal |
| Cognizin Citicoline | 250.000 mg | N/A |
| Bacopa monnieri extract | 300.000 mg | N/A |
| Aged Garlic extract powder | 400.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.